- VISTA I+II ROOM 1
- VISTA III ROOM 2
- WALKER I ROOM 3
- WALKER II ROOM 4
- GRAND IV ROOM 5
- GRAND V ROOM 6
- GRAND VI ROOM 7
- ART HALL ROOM 8
- PINE ROOM 9
09:10-10:30
KASL Symposium 1
Tailoring Hepatitis Management: From Antiviral Therapy to Post-Cure Surveillance
Chair: Man-Fung Yuen (The Univ. of Hong Kong, Hong Kong), Jong Eun Yeon (Korea Univ.)
- 09:10-09:30
-
Standardized and Individualized Criteria for Cessation of Antiviral Therapy in Chronic Hepatitis B
Hyung Joon Yim (Korea Univ.)
- 09:30-09:50
-
Monitoring and Prevention of Reactive and Progressive Properties of Occult Hepatitis B Virus Infection
Jeong Won Jang (The Catholic Univ. of Korea)
- 09:50-10:10
-
Precision Strategy for HCC Surveillance after Curing Hepatitis C: Debates across Guidelines
Tatsuya Kanto (National Center for Global Health and Medicine, Japan)
- 10:10-10:30
-
Experimental Drugs and Therapeutic Endpoints of Chronic Hepatitis D
Maria Buti (Univ. of Barcelona, Spain)
10:30-10:50
KASL Leading Research Achievement Award (*K)
- 10:30-10:50
-
Current Status of Steatotic Liver Disease in Korea
Won Kim (Seoul National Univ.)
- 10:50-11:10
Opening Ceremony
11:10-11:40
Commemorative Lecture
Chair: Young Oh Kweon (Kyungpook National Univ.)
11:40-12:40
Plenary Presentation 1
Chair: Kyung Sik Kim (Yonsei Univ.), Han Chu Lee (Univ. of Ulsan) , Kwang-Woong Lee (Seoul National Univ.)
- 11:40-11:55
-
[PP1-1] Transarterial Radioembolization versus Atezolizumab Plus Bevacizumab in Hepatocellular Carcinoma with Portal Vein Thrombosis
Youngsu Park (Seoul National Univ.)
- 11:55-12:10
-
[PP1-2] LI-RADS Imaging Diagnosis of Hepatocellular Carcinoma in Noncirrhotic Patients with Chronic Hepatitis C: A Multicenter Development and Validation Cohort
Ha Il Kim (Hanyang Univ.)
- 12:10-12:25
-
[PP1-3] Anatomical Risk Factors for Portal Vein Complications Following Right Hepatectomy in Living Donors: Analysis of Results from 4720 Cases
Young-In Yoon (Univ. of Ulsan)
- 12:25-12:40
-
[PP1-4] Persistent Systemic Inflammation Is Important Driver of Acute-on-Chronic Liver Failure and Organ Failure Development
Do Seon Song (The Catholic Univ. of Korea)
- 12:40-13:30
Luncheon Symposium 3 [Roche]
13:30-14:50
KASL-AASLD Joint Symposium
HCC Evolution: Understanding Risks and Therapeutic Approaches
Chair: W. Ray Kim (Stanford Univ., USA), Si Hyun Bae (The Catholic Univ. of Korea)
- 13:30-13:50
-
Temporal and Spatial Cancer Evolution of Dysplastic Nodules in the Liver
Ju Hyun Shim (Univ. of Ulsan)
- 13:50-14:10
-
Genomic and Epigenetic Clues to Persistent Risk of HCC after Curing Hepatitis C
Yujin Hoshida (Univ. of Texas Southwestern Medical Center, USA)
- 14:10-14:30
-
Clinical and Subclinical Risk Factors of Non-Viral HCC: Is It Preventable?
Do Young Kim (Yonsei Univ.)
- 14:30-14:50
-
Guidelines and Evidence-Based Recommendations for Sequential Systemic Therapy of HCC
Grace L. Su (Univ. of Michigan, USA)
14:50-16:10
KASL Symposium 2
Comprehensive Approaches in Alcohol-Related Liver Disease: From Genetics to Therapy
Chair: Dong Joon Kim (Hallym Univ.), Won Hyeok Choe (Konkuk Univ.)
- 14:50-15:10
-
Genetic Vulnerabilities of Alcohol-Related Hepatitis and HCC in the East and West
Jean-Charles Nault (Sorbonne Université, France)
- 15:10-15:30
-
Biomarkers in Alcohol-Related Liver Diseases
Pierre-Emmanuel Rautou (Université Paris-Cité, France)
- 15:30-15:50
-
Principles of and Debates on Indication and Duration of Use of Corticosteroids in Severe Alcoholic Hepatitis
Young Kul Jung (Korea Univ.)
- 15:50-16:10
-
Optimal Timing of Liver Transplantation in Severe Alcoholic Hepatitis
Julie K. Heimbach (Mayo Clinic, USA)
08:00-09:00
Meet the Editor CMH & AASLD Journals
Chair: Guadalupe Garcia-Tsao (Yale Univ., USA), Yoon Jun Kim (Seoul National Univ.)
- 08:00-08:15
-
Tips for Getting an Acceptance from AASLD Journals
Elliot B. Tapper (Univ. of Michigan, USA)
- 08:15-08:30
-
Tips for Getting an Acceptance from CMH
Won Kim (Seoul National Univ.)
- 08:30-08:45
-
Hepatology Editor's Picks: Noticeable Publications in 2023-2024
Yujin Hoshida (Univ. of Texas Southwestern Medical Center, USA)
- 08:45-09:00
-
CMH Editor's Picks: Noticeable Publications in 2023-2024
Seung Up Kim (Yonsei Univ.)
09:10-10:30
KLCA Symposium 1
Cutting-Edge Translational Tools for HCC
Chair: Hyunchul Rhim (Sungkyunkwan Univ.), Young Nyun Park (Yonsei Univ.)
- 09:10-09:30
-
Current and Future Perspective of Spatial Omics in HCC
Junil Kim (Soongsil Univ.)
- 09:30-09:50
-
Precision Medicine for Designing Future Clinical Trials for Immuno-Oncology Treatment
Sun Young Yim (Korea Univ.)
- 09:50-10:10
-
Radiogenomics and Radiomics in Liver Cancers
Hyungjin Rhee (Yonsei Univ.)
- 10:10-10:30
-
Discovery of Blood Biomarkers for Immune-Based Treatments of HCC: Protein vs. cfDNA/snRNA
Hye Won Lee (Yonsei Univ.)
- 10:30-10:50
-
Coffee Break
- 10:50-12:40
Opening Ceremony / Commemorative Lecture / Plenary Presentation 1 [* VISTA I+II]
- 12:40-13:30
KLCA General Meeting
13:30-14:50
KLCA-JLCA Joint Symposium
Paving the Way Forward: Novel Immunotherapy Strategies for HCC
Chair: Jong Young Choi (The Catholic Univ. of Korea), Michiie Sakamoto (Keio Univ., Japan)
- 13:30-13:50
-
Trailblazing First-Line Therapies: Which Immuno-Oncology Therapy Would be the Best for Advanced HCC?
Yong-Han Paik (Sungkyunkwan Univ.)
- 13:50-14:10
-
Navigating the Post-Immunotherapy: Second-Line Options for HCC
Masatoshi Kudo (Kindai Univ., Japan)
- 14:10-14:30
-
Overcoming Resistance and Relapse against HCC Immunotherapy
Pil Soo Sung (The Catholic Univ. of Korea)
- 14:30-14:50
-
Predictive Biomarker Research of Combination Immunotherapy: Current Status and Future Perspectives
Takahiro Kodama (Osaka Univ., Japan)
14:50-16:10
KLCA Symposium 2
Epoch-Making Changes for HCC Care
Chair: Jinsil Seong (Yonsei Univ.), Jin Wook Chung (Seoul National Univ.)
- 14:50-15:10
-
Maximizing Indication and Safety in Living Donor Liver Transplantation for HCC
Pyoung Jae Park (Korea Univ.)
- 15:10-15:30
-
Making an Impact with Radioembolization for HCC Management
Hyo-Cheol Kim (Seoul National Univ.)
- 15:30-15:50
-
Harnessing the Power of Radiotherapies for HCC Treatment
Jeong Il Yu (Sungkyunkwan Univ.)
- 15:50-16:10
-
Evolving Strategies: Treatment Patterns of HCC from Korean Claims Data
Ji Won Han (The Catholic Univ. of Korea)
16:10-16:30
HCC in Korea: The Past, Present and the Future (*K)
Chair: Hyunchul Rhim (Sungkyunkwan Univ.), Jong Young Choi (The Catholic Univ. of Korea)
- 16:10-16:30
-
HCC in Korea: The Past, Present and the Future
Hae Lim Lee (The Catholic Univ. of Korea)
09:10-10:30
Special Symposium 1
Evolving Standards in Liver Disease Management: Guidelines from Theory to Practice
Chair: Masatoshi Kudo (Kindai Univ., Japan), Woo Jin Chung (Keimyung Univ.)
- 09:10-09:30
-
Attributes and Principles for Better Practice Guidelines: An Experience on the KLCA-NCC Korea HCC Guidelines
Joong-Won Park (Myongji Hospital, Hanyang Univ.)
-
Cornerstones and Issues of High-Quality Guidelines in Recent Years
- 09:30-10:00
-
AASLD Guidelines on Clinical Assessment and Management of MASLD
Rohit Loomba (Univ. of California San Diego, USA)
- 10:00-10:30
-
EASL Guidelines on Vascular Liver Disease
Pierre-Emmanuel Rautou (Université Paris-Cité, France)
- 12:40-13:30
Luncheon Symposium 4 [Daewoong]
13:30-14:50
KASL Symposium 3
Emerging Therapies and Diagnostics in Steatotic Liver Disease
Chair: Rohit Loomba (Univ. of California San Diego, USA), Sang Hoon Park (Hallym Univ.)
- 13:30-13:50
-
Clinical Data Based on Old NAFLD and New MASLD: Shared vs. Separated
Mark Muthiah (National Univ. Hospital, Singapore)
- 13:50-14:10
-
Diagnostic Criteria and Clinical Impact of Steatotic Liver Disease Sub-Classification
Byoung Kuk Jang (Keimyung Univ.)
- 14:10-14:30
-
Pathophysiology-Based Treatment Targets and Successful Trials in MASH
Mi Na Kim (Yonsei Univ.)
- 14:30-14:50
-
Tumor Immunity and Immunotherapeutic Susceptibility of Steatotic HCC
Tetsuo Takehara (Osaka Univ., Japan)
14:50-16:10
Special Interest Group 1
Critical Care Strategies for Acute-on-Chronic Liver Failure
Chair & Panel: Barjesh Chander Sharma (Govind Ballabh Pant Hospital, India), Hong Soo Kim (Soonchunhyang Univ.)
- 14:50-15:10
-
Different Definitions and Prognostic Stratification of Acute-on-Chronic Liver Failure
Rakhi Maiwall (Institute of Liver and Biliary Sciences, India)
- 15:10-15:30
-
Respiratory Support in Acute-on-Chronic Liver Failure
Jin Won Huh (Univ. of Ulsan)
- 15:30-15:50
-
Workup and Management of Acute Kidney Injury in Patients with Acute-on-Chronic Liver Failure
Guadalupe Garcia-Tsao (Yale Univ., USA)
- 15:50-16:10
-
Panel Discussion
Speakers & 2 Panelists
- 16:10-16:30
Coffee Break
16:30-17:50
Hepatology Associates (*K)
Chair: Oh Sang Kwon (Gachon Univ.), Hee-Bok Chae (Chungbuk National Univ.)
- 16:30-16:50
-
Approach to Abnormal Liver Blood Tests of Inpatients and Outpatients
Myeong Jun Song (The Catholic Univ. of Korea)
- 16:50-17:10
-
Adverse Events of Systemic Therapy in HCC Patients: Assessment and Education
Eun Ju Cho (Seoul National Univ.)
- 17:10-17:30
-
Role of Artificial Intelligence to Assist Clinical Research Coordinators
Hyun Suk Park (Asan Medical Center)
- 17:30-17:50
-
Current Status and Prospects of Site Management Organization (SMO) in Clinical Trials
Seong Jae Kim (Gyeongsang National Univ.)
09:10-10:30
KLTS Symposium 1
Beyond Boundaries: The Promise of Liver Transplants in Unusual Situations
Chair: Gi-Won Song (Univ. of Ulsan), Wipusit Taesombat (Chulalongkorn Univ., Thailand)
- 09:10-09:30
-
Patient Selection and Result for Unresectable Hepatic Metastasis from Colorectal Cancer
Jongman Kim (Sungkyunkwan Univ.)
- 09:30-09:50
-
Perihilar Cholangiocarcinoma: Current Strategy and Future Directions
Julie K. Heimbach (Mayo Clinic, USA)
- 09:50-10:10
The Role of Liver Transplantation for Intrahepatic Cholangiocarcinoma
Ho Joong Choi (The Catholic Univ. of Korea)
- 10:10-10:30
-
HCC with Portal Vein Tumor Thrombosis
Kwangho Yang (Pusan National Univ.)
- 10:30-10:50
Coffee Break
11:40-12:40
KLTS Coordinator Session (*K)
Concerns for Living Liver Donors
Chair: Kyoung Ock Jeon (Severance Hospital), Seungheui Hong (Samsung Medical Center)
- 11:40-12:10
-
Long-Term Follow-Up and Support Programs for Living Liver Donors in Korea
YoungRok Choi (Seoul National Univ.)
- 12:10-12:25
-
Current Status of Living Liver Donor Management at Low Volume Center
Minkyung Nam (Hanyang Univ. Hospital)
- 12:25-12:40
-
Considerations for Liver Donor Management
Ji Eun Lee (Severance Hospital)
- 12:40-13:30
Luncheon Symposium 5 [AstraZeneca]
13:30-14:50
KLTS Symposium 2
A Little Less Seriously: Can Long-Term Complications Be Prevented in Liver Transplantation?
Chair: Dong-Sik Kim (Korea Univ.), Dong Jin Joo (Yonsei Univ.)
- 13:30-13:50
-
De Novo Malignancies: Long-Term Experience and Surveillance Strategy
Woo-Hyoung Kang (Univ. of Ulsan)
- 13:50-14:10
-
How to Prevent Chronic Kidney Disease after Liver Transplantation?
Jae Geun Lee (Yonsei Univ.)
- 14:10-14:30
-
Treading a Tightrope: A Strategy that Provides Minimal Immune Suppression while Reducing Rejection and Graft Fibrosis
Sanghoon Lee (Sungkyunkwan Univ.)
- 14:30-14:50
-
Physical Therapy and Exercise to Improve Quality of Life after Liver Transplantation
Won Kim (Univ. of Ulsan)
14:50-16:10
KLTS Symposium 3
Minimally Invasive Surgery for Recipients of Living Donor Liver Transplantation
Chair: Jae-Won Joh (Sungkyunkwan Univ.), Young Kyoung You (The Catholic Univ. of Korea)
- 14:50-15:10
-
Seoul National University Hospital Experience
Kwang-Woong Lee (Seoul National Univ.)
- 15:10-15:30
-
Samsung Medical Center Experience
Gyu-seong Choi (Sungkyunkwan Univ.)
- 15:30-15:50
-
Dr. Rela Institute Experience
Ashwin Rammohan (Rela Hospital, India)
- 15:50-16:10
-
Panel Discussion
07:30-08:00
KASL Branch EMW 1 [Gwangju -Chonnam]
Strategies to Reach HCV Elimination in Prevalent Lesion of Korea
Chair: Gun Young Hong (Kwangju Christian Hospital), Sung Bum Cho (Chonnam National Univ.)
- 07:30-07:45
-
Overview of HCV in Gwangju and Cheolla Province
Ga Ram You (Chonnam National Univ.)
- 07:45-08:00
-
Strategies to HCV Elimination
Jae Hyun Yoon (Chonnam National Univ.)
08:00-09:00
Radiology Seminar
LI-RADS in Focus: Past, Present, and Future Challenges in HCC Imaging
Chair: So Yeon Kim (Univ. of Ulsan), Sung Won Lee (The Catholic Univ. of Korea)
- 08:00-08:20
-
Past and Present of LI-RADS in HCC Diagnosis
Sunyoung Lee (Yonsei Univ.)
- 08:20-08:40
-
LI-RADS: It Is Time to Focus on Prognosis
Subin Heo (Univ. of Ulsan)
- 08:40-09:00
-
Future Perspectives and New Challenges in LI-RADS
Hanyu Jiang (Sichuan Univ., China)
14:50-16:30
Radioembolization Symposium
Experience of TARE for the Treatment of Liver Cancer in Asian-Pacific Region
Chair: Yoon Jun Kim (Seoul National Univ.), Pierce Chow (National Cancer Centre Singapore, Singapore)
- 14:50-14:55
-
Introduction
- 14:55-15:15
-
Recent Advances in TARE
Dongho Hyun (Sungkyunkwan Univ.)
- 15:15-15:35
-
Role of TARE in the Management of BCLC Stage A HCC
Nutcha Pinjaroen (Chulalongkorn Univ., Thailand)
- 15:35-15:55
-
Role of TARE in the Management of BCLC Stage B HCC
Pi-Yi Chang (Taichung Veterans General Hospital, Taiwan)
- 15:55-16:15
-
Role of TARE in the Management of BCLC Stage C HCC
Chow Wei Too (Singapore General Hospital, Singapore)
- 16:15-16:30
-
Closing
07:30-08:00
KASL Branch EMW 2 [Daejeon-Sejong- Chungcheong]
Chair: Tae-Hee Lee (Konyang Univ.)
- 07:30-07:50
-
Management of High-Risk HCC Patients
Myeong Jun Song (The Catholic Univ. of Korea)
- 07:50-08:00
-
Discussion
08:00-09:00
Basic Research 1 (*K)
From Cells and Systems: Spatial and Organoid Technologies
Chair: Sang Geon Kim (Dongguk Univ.), Haeng Ran Seo (Institut Pasteur Korea)
- 08:00-08:25
-
Understanding Spatial Transcriptomics in Hepatology: From Sample Preparation to Application
Kwon Joong Na (Seoul National Univ.)
- 08:25-08:50
-
Emerging Organoid Technologies to Apply for Precision Medicine in Hepatology
Myung Jin Son (Korea Research Institute of Bioscience and Biotechnology)
- 08:50-09:00
-
Discussion
09:10-10:30
Translational Research 2
Metabolic Mechanisms and Therapeutic Innovations in Hepatic Oncology
Chair: Seung Kew Yoon (The Catholic Univ. of Korea), Won-Il Jeong (KAIST)
- 09:10-09:40
-
HCC in RNA Biology: Long Concoding RNA/miRNA and Circular RNA in HCC
Jungwook Hwang (Hanyang Univ.)
- 09:40-10:05
-
Dysregulation of Liver Regeneration by Hepatitis B Virus Infection: Impact on Development of HCC
Kyun-Hwan Kim (Sungkyunkwan Univ.)
- 10:05-10:30
-
Modulation of Amino Acid Metabolism as a Therapeutic Target of Liver Cancer
Keun-Gyu Park (Kyungpook National Univ.)
13:30-14:50
Data Science Camp 1
Statistical Methodologies in Clinical Research
Chair: Geum-Youn Gwak (Sungkyunkwan Univ.), Sangwook Kang (Yonsei Univ.)
- 13:30-13:50
-
Practical Approach for Causal Inference
Danbee Kang (Sungkyunkwan Univ.)
- 13:50-14:10
-
Advanced Survival Analysis
Seo Young Park (Korea National Open Univ.)
- 14:10-14:30
-
Development of Clinical Prediction Models
Sehee Kim (Univ. of Ulsan)
- 14:30-14:50
-
Various Model Performance Measures
Seungbong Han (Korea Univ.)
14:50-16:10
Data Science Camp 2
Harnessing Health Data in Medicine
Chair: Sung Bum Cho (Chonnam National Univ.), Seungbong Han (Korea Univ.)
- 14:50-15:10
-
Common Data Model (CDM) for Observational Research
Seng Chan You (Yonsei Univ.)
- 15:10-15:30
-
AI's Role in Diagnosis and Prognosis
Kyu-Hwan Jung (Sungkyunkwan Univ.)
- 15:30-15:50
-
Big Data in Healthcare: Research and Applications
So-Ryoung Lee (Seoul National Univ.)
- 15:50-16:10
-
Guide for Radiomics Study to Clinical Researchers
Hyo Jung Park (Univ. of Ulsan)
07:30-08:00
KASL Branch EMW 3 [Gangwon]
Research Journey of Gangwon Br. of KASL: Cirrhosis and Its Complications
Chair: Gab Jin Cheon (Univ. of Ulsan)
- 07:30-07:40
-
History and Clinical Indications of NSBB
Seul Ki Han (Yonsei Univ. Wonju)
- 07:40-07:50
-
New Insights of SEPSIS-3
Tae-Suk Kim (Kangwon National Univ.)
- 07:50-08:00
-
Panel Discussion
Panelist: Sang Gyune Kim (Soonchunhyang Univ.), Moon Young Kim (Yonsei Univ. Wonju)
08:00-09:00
Industry Forum 1 with Yuhan, Daewoong, and Gilead (*K or E)
- 08:00-08:20
-
MASH (Metabolic Steatohepatitis) & Fibrosis, and Beyond
Se-Woong Oh (Yuhan Corp.)
- 08:20-08:40
-
Re-evaluation of the Efficacy of UDCA Tab. 100mg in Liver Function Improvement
Hye Jung Lee (Daewoong Pharmaceutical Co., Ltd.), Jae Young Jang (Soonchunhyang Univ.)
- 08:40-09:00
-
Gilead's Commitment to Liver Diseases
Leland Yee (Gilead Sciences, USA)
07:30-08:00
KASL Branch EMW 4 [Gyeonggi-Incheon]
Chair: Soon Woo Nam ( The Catholic Univ. of Korea)
- 07:30-07:40
-
Before and After TIPS: Practical Insights from the Perspective of Internal Medicine
Min Kyung Park (Seoul National Univ.)
- 07:40-07:50
-
Before and After TIPS: Practical Insights from the Perspective of Radiology
Tae Won Choi (Ajou Univ.)
- 07:50-08:00
-
Discussion
09:10-10:30
KLTS-KAHBPS-KLCA Joint Symposium
Multidisciplinary Approaches for HCC with Bile Duct Invasion
Chair: Yi-Hsiang Huang (National Yang Ming Chiao Tung Univ., Taiwan), Kyung-Suk Suh (Seoul National Univ.)
- 09:10-09:20
-
Case Presentation 1. Internal Medicine
Yuri Cho (National Cancer Center)
- 09:20-09:30
-
Case Presentation 2. Surgery
Jae Geun Lee (Yonsei Univ.)
- 09:30-09:50
-
Endoscopic and Percutaneous Biliary Decompression
Sang Hyub Lee (Seoul National Univ.)
- 09:50-10:10
-
Transarterial Intervention Treatments
Dongho Hyun (Sungkyunkwan Univ.)
- 10:10-10:30
-
Liver Resection and Transplantation
Xiao Xu (Zhejiang Univ., China)
- 12:40-13:30
Luncheon Symposium 6 [Dong A-ST]
13:30-14:50
Health Insurance / Policy Forum (*K)
Chair: In Hee Kim (Jeonbuk National Univ.), Hyun Woong Lee (Yonsei Univ.)
Panelist: Jin Sun Yang (Korea Disease Control and Prevention Agency)
- 13:30-13:50
-
Quality Assessment of Liver Cancer Care in Korea: A Comprehensive Approach and Future Challenge
Nam Young Kim (Health Insurance Review & Assessment Service)
- 13:50-14:10
-
Process and Criteria for the Reimbursement of Oncologic Pharmacotherapies
Mi Young Kang (Health Insurance Review & Assessment Service)
- 14:10-14:30
-
Management Model after Screening for Viral Hepatitis B and C in Korea
Young Chang (Soonchunhyang Univ.)
- 14:30-14:50
-
Local Government-Based Hepatitis C Elimination Project: Jeollanam-do Performance Report
Min-Ho Shin (Chonnam National Univ.)
14:50-16:10
KLTS-KAHBPS-KASL Joint Symposium
Updates on Cystic Liver Disease
Chair: Jin-Woo Lee (Inha Univ.), Alfred Kow (National Univ. of Singapore, Singapore)
- 14:50-15:10
-
Epidemiologic and Genetic Landscapes of Polycystic Liver Disease
Beom Kyung Kim (Yonsei Univ.)
- 15:10-15:30
-
Radiological Diagnosis for Cystic Liver Disease
Seung Baek Hong (Pusan National Univ.)
- 15:30-15:50
-
EUS-Guided or Percutaneous Therapies for Cystic Liver Disease
Dong-Wan Seo (Univ. of Ulsan)
- 15:50-16:10
-
Surgical Treatments of Large Hepatic Cysts
Seoung Yoon Rho (Yonsei Univ.)
08:00-08:40
Industry Forum 2 with Roche and Eisai (*K or E)
Moderator: Yu Rim Lee (Kyungpook National Univ,)
- 08:00-08:20
-
Developing the Next Generation of Treatments for HCC: A Perspective from Roche/Genentech
Steve Hack (Genentech)
- 08:20-08:40
-
Corporate Social Innovation (Eisai, Human Health Care Company)
Jessie Jeong Ju Seo (Eisai Korea Inc.)
